Comerica Securities Inc. lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 18,709 shares of the healthcare conglomerate’s stock after selling 84 shares during the quarter. Comerica Securities Inc.’s holdings in UnitedHealth Group were worth $3,469,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Blue Chip Partners Inc. bought a new stake in UnitedHealth Group in the second quarter valued at about $110,000. Kings Point Capital Management increased its stake in UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after acquiring an additional 150 shares during the period. Mitsubishi UFJ Securities Holdings Co. Ltd. grew its stake in UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after buying an additional 520 shares during the last quarter. BDO Wealth Advisors LLC bought a new stake in UnitedHealth Group during the second quarter worth about $121,000. Finally, Founders Capital Management bought a new stake in UnitedHealth Group during the first quarter worth about $135,000. 85.71% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Incorporated (UNH) opened at $212.60 on Wednesday. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. The firm has a market cap of $205,550.00, a P/E ratio of 21.86, a P/E/G ratio of 1.56 and a beta of 0.64. UnitedHealth Group Incorporated has a twelve month low of $150.00 and a twelve month high of $213.93.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. The company had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period last year, the business posted $2.17 earnings per share. equities analysts predict that UnitedHealth Group Incorporated will post 9.99 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be issued a $0.75 dividend. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $3.00 annualized dividend and a yield of 1.41%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.09%.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total value of $1,117,144.00. Following the sale, the director now directly owns 60,834 shares in the company, valued at $12,135,774.66. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Kenneth Irwin Shine sold 457 shares of the stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71. The disclosure for this sale can be found here. Over the last quarter, insiders sold 57,606 shares of company stock worth $11,433,133. Company insiders own 0.89% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Comerica Securities Inc. Has $3.47 Million Position in UnitedHealth Group Incorporated (UNH)” was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another website, it was stolen and republished in violation of United States & international copyright & trademark legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/comerica-securities-inc-has-3-47-million-position-in-unitedhealth-group-incorporated-unh/1718966.html.

Several brokerages have weighed in on UNH. Leerink Swann reaffirmed a “buy” rating and set a $240.00 price objective (up from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective on the stock in a research note on Thursday, September 21st. Cantor Fitzgerald upped their price objective on shares of UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 18th. Oppenheimer Holdings, Inc. upped their price objective on shares of UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 18th. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating and set a $219.00 price objective (up from $210.00) on shares of UnitedHealth Group in a research note on Thursday, October 19th. Three investment analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $216.65.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.